Skip to main content

Natpara FDA Approval History

FDA Approved: Yes (First approved January 23, 2015)
Brand name: Natpara
Generic name: parathyroid hormone
Dosage form: Injection
Company: NPS Pharmaceuticals, Inc.
Treatment for: Hypoparathyroidism

Natpara (parathyroid hormone) is recombinant human parathyroid hormone 1-84 indicated to control hypocalcemia in patients with hypoparathyroidism.

Development timeline for Natpara

Jan 23, 2015Approval FDA Approves Natpara (parathyroid hormone) for Hypocalcemia in Patients with Hypoparathyroidism
Sep  5, 2012NPS Pharmaceuticals Expects to File Natpara BLA in Mid-2013

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.